Its structural modifications allow prolonged receptor engagement and once-weekly dosing
1 Introduction Erectile dysfunction (ED), defined as the inability to achieve and maintain an erection sufficient for sexual intercourse, is estimated to occur in 20% of men over the age of 40 and the incidence increases with age ( A recent retrospective cohort study suggested that GLP-1RAs might have induced positive vasculature effects, thereby improving erectile function in patients with T2D ( Mendelian randomization (MR) can generate more reliable evidence with less confounding and reverse causation by using genetic variants related to the exposure or drug target for causal inference and prediction of potential adverse outcomes for a specific drug target ( 2 Methods 2.1 Study design The drug target MR analysis was employed to investigate whether GLP-1RAs causally link to the risk of ED ( Figure 1 )
B., Griebeler, M
L-carnitina para el corazn Un grupo de investigadores de la Universidad de Sevilla, liderado por Carmen Mara Vzquez Cueto, ha solicitado a la Oficina Espaola de Patentes y Marcas la patente del descubrimiento de la L-carnitina como sustancia para la prevencin o el tratamiento de alteraciones cardiacas asociadas a la hipertensin arterial
As an antioxidant, CoQ 10 has demonstrated to be potentially used as a treatment in diseases which have oxidative stress as a hallmark in their aetiologies
Fitting Tirzepatide into the T2D Treatment Continuum Tirzepatide is effective across the T2D treatment continuum, from initial drug therapy through to those not at target on basal insulin (mean T2D duration 4.713.3 years in the SURPASS studies) [8,9,10,11,12]
